{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:44:23Z","timestamp":1768261463229,"version":"3.49.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,26]]},"DOI":"10.7759\/cureus.10062","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T22:23:22Z","timestamp":1598480602000},"source":"Crossref","is-referenced-by-count":3,"title":["A Case Report on Bortezomib-Induced Bilateral Chalazion"],"prefix":"10.7759","author":[{"given":"Mahati","family":"Paravathaneni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vihitha","family":"Thota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Mulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Thirumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Y","family":"Thar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4236\/crcm.2015.41008","article-title":"Bortezomib-induced multiple chalazia: a case report","volume":"4","author":"Mohamed R","year":"2015","unstructured":"Mohamed R, Massa H, Schwarz C, Grandjean-Hallez N, Samii K. Bortezomib-induced multiple chalazia: a case report. Case Rep Clin Med. 2015, 4:32-35. 10.4236\/crcm.2015.41008","journal-title":"Case Rep Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2015.5729","article-title":"Chalazia development in multiple myeloma: a new complication associated with bortezomib therapy","volume":"7","author":"Yun C","year":"2015","unstructured":"Yun C, Mukhi N, Kremer V, Shinder R, Verma V, Olcay B. Chalazia development in multiple myeloma: a new complication associated with bortezomib therapy. Hematol Rep. 2015, 7:5729. 10.4081\/hr.2015.5729","journal-title":"Hematol Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.3963","article-title":"Association between bortezomib therapy and eyelid chalazia","volume":"134","author":"Fraunfelder FW","year":"2016","unstructured":"Fraunfelder FW, Yang HK. Association between bortezomib therapy and eyelid chalazia. JAMA Ophthalmol. 2016, 134:88-90. 10.1001\/jamaophthalmol.2015.3963","journal-title":"JAMA Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.5743.57","article-title":"Ocular complications of bortezomib therapy in multiple myeloma","volume":"124","author":"Puri S","year":"2014","unstructured":"Puri S, Joshi J, Derman O, Kornblum N, Verma A, Braunschweig I, Battini R. Ocular complications of bortezomib therapy in multiple myeloma. Blood. 2014, 124:5743. 10.1182\/blood.V124.21.5743.57","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25382","article-title":"Bortezomib ocular toxicities: outcomes with ketotifen","volume":"94","author":"Dennis M","year":"2019","unstructured":"Dennis M, Maoz A, Hughes D, Sanchorawala V, Sloan JM, Sarosiek S. Bortezomib ocular toxicities: outcomes with ketotifen. Am J Hematol. 2019, 94:E80-E82. 10.1002\/ajh.25382","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-019-1118-x","article-title":"Management and outcomes of proteasome inhibitor associated chalazia and blepharitis: a case series","volume":"19","author":"Sklar BA","year":"2019","unstructured":"Sklar BA, Gervasio KA, Leng S, Ghosh A, Chari A, Wu AY. Management and outcomes of proteasome inhibitor associated chalazia and blepharitis: a case series. BMC Ophthalmol. 2019, 19:110. 10.1186\/s12886-019-1118-x","journal-title":"BMC Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1179\/102453311X13025568941880","article-title":"Bortezomib in patients with renal impairment","volume":"16","author":"Kaygusuz I","year":"2011","unstructured":"Kaygusuz I, Toptas T, Aydin F, Uzay A, Firatli-Tuglular T, Bayik M. Bortezomib in patients with renal impairment. Hematology. 2011, 16:200-208. 10.1179\/102453311X13025568941880","journal-title":"Hematology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40278-014-3452-3","article-title":"Bortezomib","volume":"1519","author":"Anonymous","year":"2014","unstructured":"Anonymous. Bortezomib. React Wkly. 2014, 1519:33. 10.1007\/s40278-014-3452-3","journal-title":"React Wkly"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/37660-a-case-report-on-bortezomib-induced-bilateral-chalazion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:22:10Z","timestamp":1707506530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/37660-a-case-report-on-bortezomib-induced-bilateral-chalazion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.10062","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,26]]}}}